☰

Sajni Josson, Ph.D. - Publications

Affiliations: 
2006 University of Kentucky, Lexington, KY 
Area:
Toxicology, Radiology
Tree Info Grants Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Chu GC, Chung LWK, Gururajan M, Hsieh CL, Josson S, Nandana S, Sung SY, Wang R, Wu JB, Zhau HE. Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics. Asian Journal of Urology. 6: 65-81. PMID 30775250 DOI: 10.1016/J.Ajur.2018.11.003  0.476
2017 Josson S, Gururajan M, W K Chung L. miRNA Characterization from the Extracellular Vesicles. Bio-Protocol. 7: e2139. PMID 34458459 DOI: 10.21769/BioProtoc.2139  0.313
2015 Josson S, Chung LW, Gururajan M. microRNAs and Prostate Cancer. Advances in Experimental Medicine and Biology. 889: 105-18. PMID 26658999 DOI: 10.1007/978-3-319-23730-5_7  0.551
2015 Gururajan M, Cavassani KA, Sievert M, Duan P, Lichterman J, Huang JM, Smith B, You S, Nandana S, Chu GC, Mink S, Josson S, Liu C, Morello M, Jones LW, et al. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Oncotarget. PMID 26624980 DOI: 10.18632/Oncotarget.6398  0.529
2015 Josson S, Gururajan M, Sung SY, Hu P, Shao C, Zhau HE, Liu C, Lichterman J, Duan P, Li Q, Rogatko A, Posadas EM, Haga CL, Chung LW. Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene. 34: 2690-9. PMID 25065597 DOI: 10.1038/Onc.2014.212  0.542
2014 Gururajan M, Josson S, Chu GC, Lu CL, Lu YT, Haga CL, Zhau HE, Liu C, Lichterman J, Duan P, Posadas EM, Chung LW. miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6559-69. PMID 25324143 DOI: 10.1158/1078-0432.Ccr-14-1784  0.498
2014 Josson S, Gururajan M, Hu P, Shao C, Chu GY, Zhau HE, Liu C, Lao K, Lu CL, Lu YT, Lichterman J, Nandana S, Li Q, Rogatko A, Berel D, et al. miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4636-46. PMID 24963047 DOI: 10.1158/1078-0432.Ccr-14-0305  0.554
2014 Nomura T, Huang WC, Zhau HE, Josson S, Mimata H, Chung LW. β2-Microglobulin-mediated signaling as a target for cancer therapy. Anti-Cancer Agents in Medicinal Chemistry. 14: 343-52. PMID 23848204 DOI: 10.2174/18715206113139990092  0.501
2013 Li X, Chen YT, Josson S, Mukhopadhyay NK, Kim J, Freeman MR, Huang WC. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells. Plos One. 8: e70987. PMID 23951060 DOI: 10.1371/Journal.Pone.0070987  0.632
2013 Josson S, Matsuoka Y, Gururajan M, Nomura T, Huang WC, Yang X, Lin JT, Bridgman R, Chu CY, Johnstone PA, Zayzafoon M, Hu P, Zhau H, Berel D, Rogatko A, et al. Inhibition of β2-microglobulin/hemochromatosis enhances radiation sensitivity by induction of iron overload in prostate cancer cells. Plos One. 8: e68366. PMID 23874600 DOI: 10.1371/Journal.Pone.0068366  0.574
2013 Liu CM, Hsieh CL, He YC, Lo SJ, Liang JA, Hsieh TF, Josson S, Chung LW, Hung MC, Sung SY. In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression. Plos One. 8: e53795. PMID 23342005 DOI: 10.1371/Journal.Pone.0053795  0.644
2012 Pen CC, Liu CM, Lin CC, Lin CC, Hsieh TF, Josson S, He YC, Chung LW, Lin KL, Sung SY. Combined Dynamic Alterations in Urinary VEGF Levels and Tissue ADAM9 Expression as Markers for Lethal Phenotypic Progression of Prostate Cancer. The Chinese Journal of Physiology. 55: 390-7. PMID 23286446 DOI: 10.4077/Cjp.2012.Baa075  0.558
2011 Zhang S, Wang X, Osunkoya AO, Iqbal S, Wang Y, Chen Z, Müller S, Chen Z, Josson S, Coleman IM, Nelson PS, Wang YA, Wang R, Shin DM, Marshall FF, et al. EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene. 30: 4941-52. PMID 21625216 DOI: 10.1038/Onc.2011.199  0.531
2011 Josson S, Nomura T, Lin JT, Huang WC, Wu D, Zhau HE, Zayzafoon M, Weizmann MN, Gururajan M, Chung LW. β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Research. 71: 2600-10. PMID 21427356 DOI: 10.1158/0008-5472.Can-10-3382  0.509
2011 Josson S, Anderson CS, Sung SY, Johnstone PA, Kubo H, Hsieh CL, Arnold R, Gururajan M, Yates C, Chung LW. Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. The Prostate. 71: 232-40. PMID 20672324 DOI: 10.1002/Pros.21237  0.592
2010 Xu Y, Fang F, Zhang J, Josson S, St Clair WH, St Clair DK. miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes. Plos One. 5: e14356. PMID 21203553 DOI: 10.1371/Journal.Pone.0014356  0.437
2010 Josson S, Sharp S, Sung SY, Johnstone PA, Aneja R, Wang R, Gururajan M, Turner T, Chung LW, Yates C. Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells. Journal of Oncology. 2010. PMID 20798867 DOI: 10.1155/2010/232831  0.501
2010 Josson S, Matsuoka Y, Chung LW, Zhau HE, Wang R. Tumor-stroma co-evolution in prostate cancer progression and metastasis. Seminars in Cell & Developmental Biology. 21: 26-32. PMID 19948237 DOI: 10.1016/J.Semcdb.2009.11.016  0.566
2010 Xu Y, Fang F, Josson S, Clair DKS, Clair WHS. Abstract 2055: miR-17-3p suppresses tumorigencity of prostate cancer through inhibiting mitochondrial antioxidant enzymes Cancer Research. 70: 2055-2055. DOI: 10.1158/1538-7445.Am10-2055  0.401
2010 Jen-Tai L, Josson S, Huang W, Zhau H, Chung L. 1188 EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) AND ITS REVERSAL CAN BE PROVOKED BY IRON-MEDIATED OXIDATIVE STRESS SIGNALING IN HUMAN PROSTATE CANCER CELLS Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.689  0.507
2010 Matsuoka Y, Josson S, Gururajan M, Yang X, Chung L. 239 RADIATION SENSITIZATION BY A CYTOTOXIC ANTI-β2-MICROGLOBULIN ANTIBODY FOR THE TREATMENT OF PROSTATE CANCER IN EXPERIMENTAL MODELS Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.297  0.487
2009 Xu Y, Josson S, Fang F, Oberley TD, St Clair DK, Wan XS, Sun Y, Bakthavatchalu V, Muthuswamy A, St Clair WH. RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity. Cancer Research. 69: 3267-71. PMID 19351823 DOI: 10.1158/0008-5472.Can-08-4635  0.573
2009 Matsuoka Y, Josson S, Huang W, Marshall FF, Chung LW. MOLECULAR BASIS OF RADIATION AND CHEMOTHERAPY SENSITIZATION BY ANTI-β2-MICROGLOBULIN ANTIBODY IN HUMAN PROSTATE CANCER CELLS AND TUMOR XENOGRAFTS Journal of Urology. 181: 514-515. DOI: 10.1016/S0022-5347(09)61453-1  0.536
2008 Xu Y, Fang F, St Clair DK, Sompol P, Josson S, St Clair WH. SN52, a novel nuclear factor-kappaB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation. Molecular Cancer Therapeutics. 7: 2367-76. PMID 18723484 DOI: 10.1158/1535-7163.Mct-08-0238  0.627
2008 Josson S, Sung SY, Lao K, Chung LW, Johnstone PA. Radiation modulation of microRNA in prostate cancer cell lines. The Prostate. 68: 1599-606. PMID 18668526 DOI: 10.1002/Pros.20827  0.485
2007 Xu Y, Fang F, St Clair DK, Josson S, Sompol P, Spasojevic I, St Clair WH. Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells. Molecular Cancer Therapeutics. 6: 2048-56. PMID 17604335 DOI: 10.1158/1535-7163.Mct-06-0700  0.534
2007 Josson S, Sung S, Lao K, Chung L, Johnstone P. Radiation Modulation of MicroRNA in Prostate Cancer Cells International Journal of Radiation Oncology*Biology*Physics. 69: S352. DOI: 10.1016/J.Ijrobp.2007.07.1441  0.603
2006 Josson S, Xu Y, Fang F, Dhar SK, Clair DKS, Clair WHS. RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells Oncogene. 25: 1554-1559. PMID 16261162 DOI: 10.1038/Sj.Onc.1209186  0.629
2005 St. Clair W, Josson S, Xu Y, Fang F, Dhar S, St. Clair D. Selective Inhibition of Rel-B Suppresses Intrinsic Radiation Resistance of Prostate Cancer Cells International Journal of Radiation Oncology*Biology*Physics. 63: S485. DOI: 10.1016/J.Ijrobp.2005.07.826  0.555
Show low-probability matches.